GSA Capital Partners’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-5
Closed -$64K 1619
2018
Q2
$64K Buy
+5
New +$64K ﹤0.01% 1614